Fanaptum (iloperidone)
- Region
- 🇪🇺 EU
- Active substance
- iloperidone
- Company
- Vanda Pharmaceuticals Ltd
- Status
- Refused
- Therapeutic area
- Schizophrenia
- CHMP opinion
- Thu 09 Nov 2017
- Application
- EMEA/H/C/004149
- ATC
- N05AX14
- Official record
- www.ema.europa.eu
Indication
Treatment of schizophrenia
Regulatory milestones
No milestones recorded in the last year.
Same substance in other markets
- 🇪🇺 Iloperidone Vanda Pharmaceuticals Refused · Vanda Pharmaceuticals Netherlands B.V.
- 🇪🇺 Fanaptum Application withdrawn · Vanda Pharmaceuticals Ltd
Follow Fanaptum
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.